Johnson & Johnson to appeal stent ruling
JUN. 16 6:53 A.M. ET Cordis Corp., a unit of drug manufacturer Johnson & Johnson, said late Thursday it would appeal a federal court's decision to uphold a previous ruling that its stent product infringed on a Boston Scientific Corp. patent.
Johnson & Johnson had asked the U.S. District Court in Delaware to overturn the 2005 verdict. The jury verdict had said Johnson & Johnson's Cypher stent product infringed up a Boston Scientific drug coating paten
· Read The Full Boston Scientific Taxus Stent Article From BusinessWeek -->
·
Read All Boston Scientific Taxus Stent News Stories -->